PRRT2 and uveal melanoma: Yet for GNAQ/11Q209L-driven uveal melanoma, super-activation of the Gαq/11-Q209L-stimulated PKC pathway could provide two distinct mechanisms of therapy: (1) PKC-activated feedback reduction of Gαq/11 oncoprotein abundance or (2) inducement of cancer cell apoptosis.